Moral diversity and the challenge of responsibility in AI-CDSS
Clinical Snapshot
PICO Framework
| P — Population | Healthcare professionals, patients, and institutional stakeholders operating within AI-assisted clinical decision support environments |
| I — Intervention | Integration of artificial intelligence in clinical decision support systems (AI-CDSS), incorporating machine learning methods for diagnostics and therapy |
| C — Comparator | No explicit comparator; the paper is a philosophical/ethical analysis rather than an empirical intervention study |
| O — Outcomes | Conceptual clarity regarding responsibility attribution and diffusion in AI-mediated clinical decision-making, with attention to moral diversity, algorithmic bias, clinician-patient interaction, and patient autonomy |
Bottom Line
This philosophical paper makes a timely and intellectually substantive contribution to the ethics of AI in healthcare by foregrounding moral diversity as a structural challenge to responsibility attribution in AI-CDSS. The authors argue, through a relational responsibility framework, that the coexistence of differing moral values among clinicians, patients, and institutions is not merely a background condition but an active complicating factor that intensifies ethical complexity in AI-mediated care. The three domains examined — algorithmic bias, clinician-patient interaction, and patient roles — are well chosen and clinically recognisable. However, senior clinicians should note that this is a normative theoretical paper, not an empirical study. Its conclusions, while philosophically coherent, are not derived from patient data, clinical observation, or systematic evidence synthesis. The practical implications for bedside practice, institutional governance, or AI procurement remain to be developed. For Australian clinicians and health system leaders, the paper's core message is actionable in principle: ethical frameworks governing AI-CDSS must be sensitive to the moral plurality of real clinical environments, and responsibility cannot be defaulted to the technology itself. This should inform local ethics committee deliberations, AI governance policies, and clinical training programmes.
Key Findings
Effect Size: Not applicable — normative philosophical analysis; no quantitative effect size reported
Primary Outcome: Moral diversity — the coexistence of varying moral values, cultural beliefs, and ethical frameworks among healthcare professionals, patients, and institutional stakeholders — substantially complicates the attribution and diffusion of responsibility in AI-CDSS-mediated clinical decision-making
Nnt Or Sensitivity: Not applicable — the paper's equivalent metric is the conceptual force of its argument: it identifies three specific domains (algorithmic bias, clinician-patient interaction, patient roles) where moral diversity intensifies ethical complexity, and argues that a unified normative standard for responsibility attribution is neither achievable nor desirable without greater ethical sensitivity to this plurality
Confidence Interval: Not applicable — no empirical data or statistical analysis conducted
Clinical Application
The paper's recommendations — greater ethical sensitivity in AI-CDSS development and application — are directionally sound but operationally underspecified. Implementation would require translation into concrete governance structures, ethics training curricula, and AI procurement criteria. Feasibility is moderate in well-resourced health systems with existing clinical ethics infrastructure, but lower in resource-constrained settings. Highly relevant to the Australian healthcare context. The TGA has issued guidance on software as a medical device (SaMD), which encompasses AI-CDSS, but regulatory frameworks for responsibility attribution remain underdeveloped. The RACGP has acknowledged AI's role in general practice but lacks detailed ethical guidance on moral diversity in AI-mediated consultations. Australia's multicultural patient population — with significant Indigenous, migrant, and culturally and linguistically diverse communities — makes the moral diversity argument particularly pressing. The Australian Digital Health Agency's National Digital Health Strategy and the proposed AI in Health framework would benefit from incorporating the relational responsibility concepts discussed in this paper. PBS and MBS implications arise if AI-CDSS influence prescribing or diagnostic coding decisions, raising questions about who bears responsibility for AI-influenced clinical errors. All healthcare professionals involved in AI-assisted clinical decision-making, including physicians, nurses, allied health professionals, clinical informaticists, and health system administrators; also relevant to AI developers, ethics committees, and health policy makers
Abstract
The increasing integration of artificial intelligence in clinical decision support systems (AI-CDSS) has fueled expectations of more personalized and effective diagnostics and therapies. By incorporating machine learning methods, AI-CDSS promise enhanced predictive accuracy, improved stratification, and innovative individualized care. However, this technological optimism is accompanied by complex ethical challenges, including issues of explainability, trust, autonomy, and data security. At the core of these debates lies the question of responsibility, which involves both its attribution and diffusion, as well as the underlying normative standards guiding moral action. In the context of healthcare practice, responsibility is further complicated by moral diversity-the coexistence of varying moral values, cultural beliefs, and ethical frameworks among healthcare professionals, patients, and institutional stakeholders. This plurality challenges the establishment of a unified normative standard necessary for ethically sound responsibility attribution. This paper offers an analysis of moral diversity and AI-CDSS as a challenge for responsibility in healthcare environments. Using a relational concept of responsibility the study examines key areas in which moral diversity affects responsibility in AI-mediated decision-making. This includes algorithmic bias, healthcare professional and patient interaction and the role of patients. Through these examples, the paper explains how different normative standards intensify ethical complexity in AI-supported clinical contexts. It argues that greater ethical sensitivity to moral diversity is essential-both in the development of AI-CDSS and in their application within morally value-laden healthcare situations.
References
- 1.Liedtke, W., & Langanke, M. (2026). Moral diversity and the challenge of responsibility in AI-CDSS. Philosophy, Ethics, and Humanities in Medicine. https://doi.org/10.1136/medethics-2020-106786
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service